| Matthew Ward Cross, MD | |
|
1215 Lee St, Charlottesville, VA 22908-0816 | |
| (434) 982-0629 | |
| (434) 982-0019 |
| Full Name | Matthew Ward Cross |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 1215 Lee St, Charlottesville, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689178402 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 0101275673 (Virginia) | Primary |
| Entity Name | Acv Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881927259 PECOS PAC ID: 3870633936 Enrollment ID: O20091221000602 |
News Archive
NanoViricides, Inc. reported today that its oral FluCide drug candidates demonstrated dramatically improved survival in animals administered a lethal dose of the H3N2 influenza A virus.
There is no good evidence supporting a harmful effect of exercise on joints in the setting of normal joints and regular exercise, according to a review of studies published in this month's issue of the Journal of Anatomy.
Phenomix Corporation today announced it has begun administering subjects in a Phase 1a clinical trial of PHX1766, the company's internally discovered, orally available NS3/4A protease inhibitor for the treatment of chronic hepatitis C virus (HCV) infection.
Osiris Therapeutics, Inc. announced today that the Biologics and Genetic Therapies Directorate of Health Canada has completed its initial evaluation and accepted for full review the company's New Drug Submission (NDS) of Prochymal (remestemcel-L), an adult stem cell therapy for the treatment of graft vs. host disease (GvHD). Based on a separate review of summary clinical data, Health Canada has notified Osiris that the application has been granted Priority Review, shortening the examination period from 300 to 180 days.
President Obama has asked Congress to deliver a bill by October that would "cut healthcare costs and provide medical coverage to most of the 46 million uninsured Americans," a goal that may no longer be realistic as members of the president's own party move to stall efforts, the Reuters/The Washington Post reports (Allen, 7/9).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Ward Cross, MD 1215 Lee St Box 800710, Charlottesville, VA 22908-0816 Ph: (434) 982-0629 | Matthew Ward Cross, MD 1215 Lee St, Charlottesville, VA 22908-0816 Ph: (434) 982-0629 |
News Archive
NanoViricides, Inc. reported today that its oral FluCide drug candidates demonstrated dramatically improved survival in animals administered a lethal dose of the H3N2 influenza A virus.
There is no good evidence supporting a harmful effect of exercise on joints in the setting of normal joints and regular exercise, according to a review of studies published in this month's issue of the Journal of Anatomy.
Phenomix Corporation today announced it has begun administering subjects in a Phase 1a clinical trial of PHX1766, the company's internally discovered, orally available NS3/4A protease inhibitor for the treatment of chronic hepatitis C virus (HCV) infection.
Osiris Therapeutics, Inc. announced today that the Biologics and Genetic Therapies Directorate of Health Canada has completed its initial evaluation and accepted for full review the company's New Drug Submission (NDS) of Prochymal (remestemcel-L), an adult stem cell therapy for the treatment of graft vs. host disease (GvHD). Based on a separate review of summary clinical data, Health Canada has notified Osiris that the application has been granted Priority Review, shortening the examination period from 300 to 180 days.
President Obama has asked Congress to deliver a bill by October that would "cut healthcare costs and provide medical coverage to most of the 46 million uninsured Americans," a goal that may no longer be realistic as members of the president's own party move to stall efforts, the Reuters/The Washington Post reports (Allen, 7/9).
› Verified 2 days ago
Farnaz M Gazoni, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Katherine T, Forkin, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Edward C. Nemergut, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Allison J. Bechtel, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Kristi Hackworth Rose, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2331 Seminole Ln Ste 201, Charlottesville, VA 22901 Phone: 434-293-4995 Fax: 434-971-3434 | |
Sunny S. Chiao, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Logan David Kinch, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 545 Ray C Hunt Dr Ste 316, Charlottesville, VA 22903 Phone: 434-243-5676 Fax: 434-243-5689 |